• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Veradigm Inc. - common stock (NQ:MDRX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 6.850 (14)
Ask (Size) 6.860 (10)
Prev. Close 6.810
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 109,259,776
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VERADIGM ALERT: Bragar Eagel & Squire, P.C. is Investigating Veradigm Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 31, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Veradigm Payerpath Rated Highest in Client Satisfaction
May 30, 2024
From Veradigm
Via Business Wire

Performance

More News

Read More
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
May 28, 2024
From Veradigm Inc.
Via Business Wire
Veradigm Announces Leadership Updates
May 28, 2024
From Veradigm
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
May 16, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
Law Offices of Howard G. Smith Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
May 15, 2024
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
May 14, 2024
From Law Offices of Frank R. Cruz
Via Business Wire
Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings
April 09, 2024
From Veradigm
Via Business Wire
Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 14, 2024
From Veradigm Inc.
Via Business Wire
Veradigm Announces Initial Financial Guidance for Fiscal 2024
March 13, 2024
From Veradigm Inc.
Via Business Wire
Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024
From Veradigm
Via Business Wire
Veradigm Completes Acquisition of ScienceIO
March 04, 2024
From Veradigm Inc.
Via Business Wire
Veradigm Receives Expected Delisting Notice from Nasdaq
February 28, 2024
From Veradigm Inc.
Via Business Wire
Veradigm to Participate in TD Cowen Annual Health Care Conference
February 28, 2024
From Veradigm Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via Benzinga
Veradigm Provides Update on its Financial Restatement Process
February 27, 2024
From Veradigm Inc.
Via Business Wire
Veradigm to Acquire ScienceIO
February 27, 2024
From Veradigm Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
Via Benzinga
Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference
February 22, 2024
From Veradigm Inc.
Via Business Wire
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
February 20, 2024
From Veradigm
Via Business Wire
Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health
February 13, 2024
From Veradigm Inc.
Via Business Wire
MDRX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MDRX
January 22, 2024
Via NewMediaWire
Topics Lawsuit
MDRX MONDAY DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MDRX
January 20, 2024
Via NewMediaWire
Topics Lawsuit
VERADIGM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
January 19, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
MDRX DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MDRX
January 19, 2024
Via NewMediaWire
Topics Lawsuit

Frequently Asked Questions

Is Veradigm Inc. - common stock publicly traded?
Yes, Veradigm Inc. - common stock is publicly traded.
What exchange does Veradigm Inc. - common stock trade on?
Veradigm Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Veradigm Inc. - common stock?
The ticker symbol for Veradigm Inc. - common stock is MDRX on the Nasdaq Stock Market
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap